长期脱机:德国呼吸学会S2k指南
该S2k指南由德国呼吸学会(DGP)联合其他参与长期脱机的科学学会制定,2014年首次发布,本次修订基于新研究、临床研究结果、注册数据和日常实践经验。指南涵盖定义、流行病学、脱机分类、病理生理、长期脱机预防、治疗策略、脱机单元、带机出院及终末期决策推荐,重点包括长期脱机患者亚组新分类、肺康复与神经康复、基于持续治疗理念的基础设施与流程组织、治疗目标变化与家属沟通。约20%机械通气患者尽管诱发因素改善仍需持续通气,约40-50%的机械通气时间用于脱机;国际共识定义长期脱机为至少3次脱机尝试失败或首次自主呼吸试验后需脱机超过7天。专科脱机中心约50%初始脱机失败患者经长期脱机后可脱离呼吸机,但患者异质性妨碍中心间直接比较。
要点
- 国际共识定义长期脱机:至少3次脱机尝试失败,或首次自主呼吸试验后脱机超过7天。
- 约20%机械通气患者尽管诱发因素改善仍需持续通气,约40-50%的机械通气时间用于脱机。
- 专科脱机中心约50%初始脱机失败患者经长期脱机后可脱离呼吸机,但患者异质性妨碍中心间直接比较。
- 长期脱机是复杂过程,跨学科方法对成功至关重要;持续脱机失败患者或在脱机过程中死亡,或带机出院回家或转至长期护理机构。
- 指南重点包括长期脱机患者亚组新分类、肺康复与神经康复、基于持续治疗理念的基础设施与流程组织、治疗目标变化与家属沟通。
适用人群与场景
- 机械通气患者,用于严重呼吸衰竭由呼吸肌功能不全和/或肺实质疾病引起,且药物治疗、给氧、分泌物管理、持续气道正压(CPAP)或经鼻高流量治疗等其他治疗失败时。
- 约20%机械通气患者尽管诱发通气需求的病情改善仍需持续机械通气。
- 长期脱机患者包括至少3次脱机尝试失败或首次自主呼吸试验后需脱机超过7天者。
诊断标准与关键阈值
- 国际共识定义长期脱机:至少3次脱机尝试失败,或首次自主呼吸试验后脱机超过7天。
研究设计与关键结果
- 该S2k指南由德国呼吸学会(DGP)联合其他参与长期脱机的科学学会制定,2014年首次发布,本次修订基于新研究、临床研究结果、注册数据和日常实践经验。
- 指南涵盖定义、流行病学、脱机分类、病理生理、长期脱机预防、治疗策略、脱机单元、带机出院及终末期决策推荐。
- 重点主题包括:(1)长期脱机患者亚组新分类;(2)长期脱机中肺康复和神经康复的重要方面;(3)基于持续治疗理念的长期脱机患者护理基础设施与流程组织;(4)治疗目标变化与家属沟通。
- 儿童脱机方面在各章节中单独讨论。
- 指南主要目的为总结当前证据和专家知识,作为制定长期脱机相关推荐的基础,不仅适用于急性医学,也适用于慢性重症医学领域。
- 目标受众包括重症医学科医师、肺科医师、麻醉科医师、内科医师、心脏科医师、外科医师、神经科医师、儿科医师、老年科医师、姑息治疗临床医师、康复医师、重症/慢性护理护士、物理治疗师、呼吸治疗师、言语治疗师、健康保险医疗服务机构及相关呼吸机制造商。
证据类型、等级与局限
- 证据类型:S2k指南(德国呼吸学会发布),基于当前证据和专家知识制定。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
指南或共识出处
- Prolonged Weaning: S2k Guideline Published by the German Respiratory Society(德国呼吸学会,S2k指南)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Mechanical ventilation (MV) is an essential part of modern intensive care medicine. MV is performed in patients with severe respiratory failure caused by respiratory muscle insufficiency and/or lung parenchymal disease; that is, when other treatments such as medication, oxygen administration, secretion management, continuous positive airway pressure (CPAP), or nasal high-flow therapy have failed. MV is required for maintaining gas exchange and allows more time to curatively treat the underlying cause of respiratory failure. In the majority of ventilated patients, liberation or "weaning" from MV is routine, without the occurrence of any major problems. However, approximately 20% of patients require ongoing MV, despite amelioration of the conditions that precipitated the need for it in the first place. Approximately 40-50% of the time spent on MV is required to liberate the patient from the ventilator, a process called "weaning". In addition to acute respiratory failure, numerous factors can influence the duration and success rate of the weaning process; these include age, comorbidities, and conditions and complications acquired during the ICU stay. According to international consensus, "prolonged weaning" is defined as the weaning process in patients who have failed at least 3 weaning attempts, or require more than 7 days of weaning after the first spontaneous breathing trial (SBT). Given that prolonged weaning is a complex process, an interdisciplinary approach is essential for it to be successful. In specialised weaning centres, approximately 50% of patients with initial weaning failure can be liberated from MV after prolonged weaning. However, the heterogeneity of patients undergoing prolonged weaning precludes the direct comparison of individual centres. Patients with persistent weaning failure either die during the weaning process, or are discharged back to their home or to a long-term care facility with ongoing MV. Urged by the growing importance of prolonged weaning, this Sk2 Guideline was first published in 2014 as an initiative of the German Respiratory Society (DGP), in conjunction with other scientific societies involved in prolonged weaning. The emergence of new research, clinical study findings and registry data, as well as the accumulation of experience in daily practice, have made the revision of this guideline necessary. The following topics are dealt with in the present guideline: Definitions, epidemiology, weaning categories, underlying pathophysiology, prevention of prolonged weaning, treatment strategies in prolonged weaning, the weaning unit, discharge from hospital on MV, and recommendations for end-of-life decisions. Special emphasis was placed on the following themes: (1) A new classification of patient sub-groups in prolonged weaning. (2) Important aspects of pulmonary rehabilitation and neurorehabilitation in prolonged weaning. (3) Infrastructure and process organisation in the care of patients in prolonged weaning based on a continuous treatment concept. (4) Changes in therapeutic goals and communication with relatives. Aspects of paediatric weaning are addressed separately within individual chapters. The main aim of the revised guideline was to summarize both current evidence and expert-based knowledge on the topic of "prolonged weaning", and to use this information as a foundation for formulating recommendations related to "prolonged weaning", not only in acute medicine but also in the field of chronic intensive care medicine. The following professionals served as important addressees for this guideline: intensivists, pulmonary medicine specialists, anaesthesiologists, internists, cardiologists, surgeons, neurologists, paediatricians, geriatricians, palliative care clinicians, rehabilitation physicians, intensive/chronic care nurses, physiotherapists, respiratory therapists, speech therapists, medical service of health insurance, and associated ventilator manufacturers.
参考来源
- Schönhofer B, Geiseler J, Dellweg D, et al. Prolonged Weaning: S2k Guideline Published by the German Respiratory Society. Respiration. 2020. PMID: 33302267. doi:10.1159/000510085
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。